Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Toll-Like Receptor 3

  • Aisha Qasim Butt
  • Sinéad M. MigginEmail author
Reference work entry
First Online:
DOI: https://doi.org/10.1007/978-3-319-67199-4_607
How to cite

Synonyms

 CD283;  CD283 antigen

Historical Background

The innate immune system of mammals is equipped with various kinds of cells, such as macrophages and dendritic cells (DCs), which provides the first line of defense to the host in recognizing various kinds of pathogens. These cells have developed different classes of protein based receptors for recognizing numerous kinds of pathogen associated molecular patterns (PAMPs) (Miggin and O’Neill 2006). These different classes of pathogen recognition receptors (PRRs) includes, Membrane bound PRRs such as Toll-like receptors (TLRs), Receptor kinases, Mannose receptors and Cytoplasmic PRRssuch as Nucleotide oligomerization domain (NOD) receptors, the Retinoic acid inducible gene I (RIG-I)-like receptor (RLR) family, and the recently described AIM2 and DAI cytosolic DNA receptors. All these receptor proteins play a crucial role in “danger” recognition and induction of the innate immune responses against a variety of bacterial and viral...

This is a preview of subscription content, log in to check access.

References

  1. Bell JK, Askins J, Hall PR, Davies DR, Segal DM. The dsRNA binding site of human Toll-like receptor 3. Proc Natl Acad Sci USA. 2006;103:8792–7.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Botos I, Liu L, Wang Y, Segal DM, Davies DR. The toll-like receptor 3:dsRNA signaling complex. Biochim Biophys Acta. 2009;1789:667–74.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol. 2006;7:1074–81.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Cheng YS, Xu F. Anticancer function of polyinosinic-polycytidylic acid. Cancer Biol Ther. 2010;10:1219–23.PubMedPubMedCentralCrossRefGoogle Scholar
  5. de Bouteiller O, Merck E, Hasan UA, Hubac S, Benguigui B, Trinchieri G, et al. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem. 2005;280:38133–45.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Funami K, Matsumoto M, Oshiumi H, Akazawa T, Yamamoto A, Seya T. The cytoplasmic ‘linker region’ in Toll-like receptor 3 controls receptor localization and signaling. Int Immunol. 2004;16:1143–54.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Gauzzi C, Del Corno M, Gessani S. Dissecting TLR3 signaling in dendritic cells. Immunobiology. 2010;215:713–23.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Jin B, Sun T, Yu XH, Liu CQ, Yang YX, Lu P, et al. Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant. J Biomed Biotechnol. 2010;2010:690438.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Johnson AC, Li X, Pearlman E. MyD88 functions as a negative regulator of TLR3/TRIF-induced corneal inflammation by inhibiting activation of c-Jun N-terminal kinase. J Biol Chem. 2008;283:3988–96.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Kenny EF, Talbot S, Gong M, Golenbock DT, Bryant CE, O’Neill LA. MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. J Immunol. 2009;183:3642–51.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem J. 2009;420:1–16.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Miggin SM, O’Neill LA. New insights into the regulation of TLR signaling. J Leukoc Biol. 2006;80:220–6.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Nomura N, Nagase T, Miyajima N, Sazuka T, Tanaka A, Sato S, et al. Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1 (supplement). DNA Res. 1994;1:251–62.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature. 2006;439:208–11.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Sasai M, Tatematsu M, Oshiumi H, Funami K, Matsumoto M, Hatakeyama S, et al. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway. Mol Immunol. 2010;47:1283–91.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Schröder M, Baran M, Bowie AG. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKe-mediated IRF activation. EMBO J. 2008;27:2147–57.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Siednienko J, Miggin SM. Expression analysis of the Toll-like receptors in human peripheral blood mononuclear cells. Methods Mol Biol. 2009;517:3–14.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Siednienko J, Halle A, Nagpal K, Golenbock DT, Miggin SM. TLR3-mediated IFN-beta gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like. Eur J Immunol. 2010;40:3150–60.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Siednienko J, Gajanayake T, Fitzgerald KA, Moynagh P, Miggin SM. Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-(beta) and RANTES production. J Immunol. 2011;186:2514–22.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev. 2008;21:13–25.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Yamamoto M, Takeda K. Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract. 2010;2010:240365.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Zhou Y, Wang X, Liu M, Hu Q, Song L, Ye L, et al. A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology. 2010;131:40–9.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Biology, Institute of ImmunologyNational University of Ireland MaynoothMaynoothIreland